HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken Haruma Selected Research

lafutidine

6/2016Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.
12/2010A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis.
4/2010[Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ken Haruma Research Topics

Disease

31Neoplasms (Cancer)
11/2020 - 01/2002
26Infections
05/2022 - 02/2002
25Stomach Neoplasms (Stomach Cancer)
05/2022 - 05/2002
21Gastritis
05/2022 - 02/2002
21Gastroesophageal Reflux (GERD)
07/2021 - 01/2006
19Ulcer
12/2014 - 01/2005
17Hemorrhage
01/2021 - 01/2006
16Atrophy
05/2022 - 01/2006
15Peptic Ulcer (Peptic Ulcers)
07/2015 - 02/2002
13Dyspepsia (Indigestion)
01/2021 - 10/2007
12Peptic Esophagitis (Reflux Esophagitis)
01/2021 - 01/2006
11Atrophic Gastritis
01/2022 - 09/2003
11Carcinoma (Carcinomatosis)
11/2012 - 11/2002
9Stomach Ulcer (Gastric Ulcer)
07/2015 - 02/2004
7Carcinogenesis
11/2021 - 08/2003
7Heartburn (Pyrosis)
01/2021 - 06/2006
7Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
12/2018 - 06/2010
6Metaplasia
06/2022 - 01/2006
6Constipation
08/2019 - 06/2010
6Diarrhea
05/2018 - 08/2013
6Non-Erosive Reflux Disease
08/2016 - 08/2009
6Colorectal Neoplasms (Colorectal Cancer)
11/2014 - 01/2002
5Adenocarcinoma
04/2022 - 01/2004
5Pathologic Constriction (Stenosis)
11/2021 - 06/2008
5Inflammation (Inflammations)
01/2021 - 01/2006
5Esophagitis
04/2018 - 01/2013
5Cardiovascular Diseases (Cardiovascular Disease)
12/2014 - 01/2009
5Neoplasm Metastasis (Metastasis)
07/2014 - 01/2002
5Lymphatic Metastasis
03/2004 - 01/2002
4Disease Progression
05/2021 - 06/2008
4Duodenal Ulcer (Curling's Ulcer)
07/2009 - 04/2003
3Hiatal Hernia
01/2022 - 05/2008
3Diabetes Mellitus
09/2020 - 04/2009
3Deglutition Disorders (Dysphagia)
01/2020 - 10/2009
3Adenoma (Adenomas)
01/2019 - 10/2003
3Crohn Disease (Crohn's Disease)
01/2017 - 11/2007
3Pain (Aches)
01/2017 - 01/2009
3Ischemia
07/2012 - 08/2005
3Duodenogastric Reflux
12/2010 - 01/2008
3Hypersensitivity (Allergy)
05/2010 - 07/2008
2Hyperplasia
06/2022 - 01/2018
2Neuroendocrine Tumors (Neuroendocrine Tumor)
05/2022 - 04/2022
2Autoimmune Diseases (Autoimmune Disease)
05/2022 - 11/2021
2Fistula
01/2022 - 12/2013
2Liver Cirrhosis (Hepatic Cirrhosis)
04/2021 - 01/2021
2Polyps
04/2021 - 01/2021
2Abdominal Pain (Pain, Abdominal)
12/2018 - 02/2016
2Barrett Esophagus (Barrett's Esophagus)
01/2016 - 08/2005
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
09/2014 - 01/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2014 - 11/2002

Drug/Important Bio-Agent (IBA)

33Proton Pump InhibitorsIBA
11/2021 - 10/2007
17AcidsIBA
01/2022 - 08/2004
16Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 01/2008
14Pepsinogen A (Pepsinogen)IBA
09/2014 - 02/2002
13Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2013 - 02/2004
11GastrinsIBA
01/2022 - 02/2002
8AntralIBA
05/2022 - 05/2006
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2004 - 11/2002
6Indicators and Reagents (Reagents)IBA
01/2021 - 01/2003
6Pharmaceutical PreparationsIBA
08/2016 - 01/2005
5AntibodiesIBA
05/2022 - 01/2003
5Rabeprazole (Aciphex)FDA Link
01/2021 - 07/2014
5liu-jun-zi-tangIBA
08/2016 - 01/2010
5Lansoprazole (Prevacid)FDA LinkGeneric
06/2016 - 12/2013
5Famotidine (Pepcid)FDA LinkGeneric
12/2010 - 01/2008
5Proteins (Proteins, Gene)FDA Link
01/2010 - 05/2002
4Biomarkers (Surrogate Marker)IBA
05/2021 - 01/2003
4Omeprazole (Prilosec)FDA LinkGeneric
11/2015 - 06/2006
4Type 1 Angiotensin ReceptorIBA
04/2012 - 11/2010
4Messenger RNA (mRNA)IBA
03/2012 - 11/2002
3Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2016
3Therapeutic UsesIBA
01/2021 - 12/2004
3Warfarin (Coumadin)FDA LinkGeneric
01/2019 - 01/2009
3Serotonin (5 Hydroxytryptamine)IBA
05/2018 - 08/2013
3Clarithromycin (Biaxin)FDA LinkGeneric
12/2016 - 10/2003
3lafutidineIBA
06/2016 - 04/2010
3Capsules (Microcapsules)IBA
10/2015 - 03/2011
3rebamipideIBA
01/2015 - 01/2006
3Bile Acids and Salts (Bile Acids)IBA
09/2013 - 09/2006
3Interleukin-1beta (Interleukin 1 beta)IBA
11/2010 - 01/2009
3Biological ProductsIBA
01/2009 - 01/2006
2SteroidsIBA
06/2022 - 08/2021
2Intrinsic FactorFDA Link
06/2022 - 10/2019
2Triglycerides (Triacylglycerol)IBA
01/2022 - 09/2020
2Hemoglobins (Hemoglobin)IBA
01/2022 - 10/2019
2PlasticsIBA
01/2022 - 12/2013
2PotassiumIBA
08/2021 - 07/2014
2Urea (Carbamide)FDA LinkGeneric
03/2020 - 04/2003
2Capsaicin (Zostrix)FDA Link
01/2020 - 01/2017
2thienopyridineIBA
01/2019 - 11/2010
2Infliximab (Remicade)FDA Link
01/2017 - 06/2008
2ramosetron (Nasea)IBA
09/2016 - 02/2016
2Histamine (Histamine Dihydrochloride)FDA Link
08/2016 - 01/2008
2Dietary FiberFDA Link
12/2015 - 11/2003
2Docetaxel (Taxotere)FDA Link
07/2014 - 05/2012

Therapy/Procedure

42Therapeutics
06/2022 - 02/2002
4Gastrectomy
01/2022 - 04/2002
3Aftercare (After-Treatment)
01/2021 - 06/2006
3Drug Therapy (Chemotherapy)
05/2014 - 10/2003
2Stents
04/2022 - 01/2022